Trademark Overview
On Tuesday, April 7, 2026, a trademark application was filed for ZUNVAYO with the United States Patent and Trademark Office. The USPTO has given the ZUNVAYO trademark a serial number of 99749602. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, April 7, 2026. This trademark is owned by Eli Lilly and Company. The ZUNVAYO trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorder, alopecia, Alzheimer’s disease, asthma, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, cancer, cardiovascular disease, central nervous system diseases and disorders, Crohn’s disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, obstructive sleep apnea, osteoarthritis, pain, Parkinson’s disease, psoriasis, psoriatic arthritis, retinal disease, rheumatoid arthritis, ulcerative colitis, vascular diseases and vision l...
